Tower Research Capital »

Kairos Pharma shares owned by Tower Research Capital

Quarter-by-quarter ownership of Kairos Pharma (KAPA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Kairos Pharma

Tip: Access up to 7 years of quarterly data

All positions including Kairos Pharma held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kairos Pharma by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0k 6.0k 1.17
2025-06-30 $2.7k 3.8k 0.71

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Kairos Pharma

Vanguard Group
Geode Capital Management
Two Sigma Investments
Aptus Capital Advisors
SevenBridge Financial
Two Sigma Securities
State Street Corporation
XTX Topco
UBS Group
Tower Research Capital
Royal Bank of Canada

View all funds holding Kairos Pharma